Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin.
Boonyawat K, Lensing AWA, Prins MH, Beyer-Westendorf J, Prandoni P, Martinelli I, Middeldorp S, Pap AF, Weitz JI, Crowther M. Boonyawat K, et al. Among authors: weitz ji. Res Pract Thromb Haemost. 2021 Feb 17;5(2):308-313. doi: 10.1002/rth2.12474. eCollection 2021 Feb. Res Pract Thromb Haemost. 2021. PMID: 33733030 Free PMC article.
Direct thrombin inhibitors.
Weitz JI, Crowther M. Weitz JI, et al. Thromb Res. 2002 May 1;106(3):V275-84. doi: 10.1016/s0049-3848(02)00093-2. Thromb Res. 2002. PMID: 12356489 Review.
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Kearon C, et al. Among authors: weitz ji. N Engl J Med. 2003 Aug 14;349(7):631-9. doi: 10.1056/NEJMoa035422. N Engl J Med. 2003. PMID: 12917299 Free article. Clinical Trial.
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor.
Kearon C, Ginsberg JS, Anderson DR, Kovacs MJ, Wells P, Julian JA, Mackinnon B, Demers C, Douketis J, Turpie AG, Van Nguyen P, Green D, Kassis J, Kahn SR, Solymoss S, Desjardins L, Geerts W, Johnston M, Weitz JI, Hirsh J, Gent M; SOFAST Investigators. Kearon C, et al. Among authors: weitz ji. J Thromb Haemost. 2004 May;2(5):743-9. doi: 10.1046/j.1538-7836.2004.00698.x. J Thromb Haemost. 2004. PMID: 15099280 Free article. Clinical Trial.
Ximelagatran: the first oral direct thrombin inhibitor.
Crowther MA, Weitz JI. Crowther MA, et al. Among authors: weitz ji. Expert Opin Investig Drugs. 2004 Apr;13(4):403-13. doi: 10.1517/13543784.13.4.403. Expert Opin Investig Drugs. 2004. PMID: 15102589 Review.
Thrombophilia and new anticoagulant drugs.
Weitz JI, Middeldorp S, Geerts W, Heit JA. Weitz JI, et al. Hematology Am Soc Hematol Educ Program. 2004:424-38. doi: 10.1182/asheducation-2004.1.424. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561696 Review.
552 results